Pharmacoepidemiology and Drug Safety 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Issue Information
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 357-357, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 6, 2018 Category: Drugs & Pharmacology Source Type: research
Cover Image
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page i-i, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 6, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 6, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 356-356, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 6, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page 357-357, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 6, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 3, Page i-i, March 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 6, 2018 Category: Drugs & Pharmacology Source Type: research
Issue Information
No abstract is available for this article. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 6, 2018 Category: Drugs & Pharmacology Tags: ISSUE INFORMATION Source Type: research
Erratum
(Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 6, 2018 Category: Drugs & Pharmacology Tags: ERRATUM Source Type: research
Issue Information
No abstract is available for this article. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 6, 2018 Category: Drugs & Pharmacology Tags: ISSUE INFORMATION Source Type: research
Cover Image
The cover image, by Yinghui Duan et al., is based on the Original Report Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia, DOI: 10.1002/pds.4361. Image source: ribkhan/Adobe Stock. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 6, 2018 Category: Drugs & Pharmacology Authors: Yinghui Duan, James J. Grady, Peter C. Albertsen, Z. Helen Wu Tags: COVER IMAGE Source Type: research
Sequential surveillance for drug safety in a regulatory environment
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 5, 2018 Category: Drugs & Pharmacology Source Type: research
---
Pharmacoepidemiology and Drug Safety, Ahead of Print. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 5, 2018 Category: Drugs & Pharmacology Source Type: research
Polydrug epidemiology: Benzodiazepine prescribing and the drug overdose epidemic in the United States
ConclusionThese findings shed light on the polydrug epidemiology of the overdose epidemic. Overdose deaths are highest where elevated opioid and benzodiazepine claims coexist. Overdose levels may reflect polydrug use and misuse, requiring clinical and policy responses beyond reducing opioid prescriptions. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 1, 2018 Category: Drugs & Pharmacology Authors: Michael James Zoorob Tags: ORIGINAL REPORT Source Type: research
Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug ‐outcome associations: The case of clindamycin and Clostridium difficile infection
ConclusionsThis evaluation produced an expected result and identified several potential enhancements to the Propensity Score Matching tool. This study has important limitations. CDI risk may have been related to factors other than the inherent properties of the drugs, such as duration of use or subsequent exposures. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 1, 2018 Category: Drugs & Pharmacology Authors: Ryan M. Carnahan, Jennifer L. Kuntz, Shirley V. Wang, Candace Fuller, Joshua J. Gagne, Charles E. Leonard, Sean Hennessy, Tamra Meyer, Patrick Archdeacon, Chih ‐Ying Chen, Catherine A. Panozzo, Sengwee Toh, Hannah Katcoff, Tiffany Woodworth, Aarthi Iyer Tags: ORIGINAL REPORT Source Type: research
Utilization of drugs with pregnancy exposure registries during pregnancy
ConclusionsAmong drugs with pregnancy exposure registries, use was less during pregnancy compared with before pregnancy and to the matched nonpregnant episodes. The lower utilization during pregnancy suggests that women may be avoiding these drugs to minimize potentially harmful exposure during pregnancy. This lower utilization may increase the challenges of further studying the safety of these drugs using pregnancy exposure registries. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - March 1, 2018 Category: Drugs & Pharmacology Authors: Onyekachukwu A. Illoh, Sengwee Toh, Susan E. Andrade, Christian Hampp, Leyla Sahin, Kate Gelperin, Lockwood Taylor, Steven T. Bird Tags: ORIGINAL REPORT Source Type: research
